Attached files

file filename
10-K - 10-K - NextCure, Inc.nxtc-20191231x10k.htm
EX-31.2 - EX-31.2 - NextCure, Inc.nxtc-20191231ex3127a5bf5.htm
EX-31.1 - EX-31.1 - NextCure, Inc.nxtc-20191231ex3113ff49f.htm
EX-23.1 - EX-23.1 - NextCure, Inc.nxtc-20191231ex2312e3b4a.htm
EX-4.2 - EX-4.2 - NextCure, Inc.nxtc-20191231ex42d841f91.htm

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 10-K of NextCure, Inc. (the “Company”) for the year ended December  31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned each hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge, on the date hereof:

 

(1)   the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)   the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

 

 

 

Dated: March 12, 2020

 

 

 

 

/s/ Michael Richman

 

Name:

Michael Richman

 

Title:

President and Chief Executive Officer

 

 

 

 

 

 

Dated: March 12, 2020

 

 

 

 

/s/ Steven P. Cobourn

 

Name:

Steven P. Cobourn

 

Title:

Chief Financial Officer